 |
 |

Lymphocytic Choriomeningitis Outbreak Associated With Nude Mice in a Research Institute
Clare A. Dykewicz, MD, MPH;
Virginia M. Dato, MD;
Susan P. Fisher-Hoch, MD;
Marilyn V. Howarth, MD;
Gilda I. Perez-Oronoz, MSPH;
Stephen M. Ostroff, MD;
Howard Gary, Jr, PhD;
Lawrence B. Schonberger, MD, MPH;
Joseph B. McCormick, MD
JAMA. 1992;267(10):1349-1353.
Abstract
 |  |
Objective. —After an employee at a cancer research institute was diagnosed with lymphocytic choriomeningitis, an investigation was performed to determine the extent of lymphocytic choriomeningitis virus (LCMV) infections among the institute's employees and to identify risk factors for infection.
Design. —Retrospective cohort study.
Setting. —A US cancer research institute.
Participants. —Eighty-two of 90 institute employees.
Main Outcome Measures. —Serum LCMV antibodies.
Results. —Seven workers (9%) with definite LCMV infection (LCMV IgG antibody titer 16) and one worker (1%) with probable infection (IgG titer = 8) were identified (10% overall seroprevalence). All infected employees handled animals or animal tissues and were more likely than other animal handlers to have worked with nude mice (Mus musculus) (P<.02). Among the 31 employees who worked with nude mice at the institute, infected workers were more likely to clean the cages of nude mice (P<<.001), change their bedding (P<.01), and change their water (P<.001 ). The institute had been injecting nude mice with LCMV-infected tumor cell lines and had recently increased the nude mouse population and the duration of experiments. These changes would have increased the LCMV burden at the facility and were temporally associated with the cluster of LCMV infections in employees.
Conclusions. —This LCMV outbreak, the first reported since 1974, is the first associated with nude mice. It illustrates the ongoing hazard LCMV poses in research laboratories. Since the symptoms of LCMV infection can be nonspecific, clinicians should consider this diagnosis in ill patients who report laboratory rodent exposure.
(JAMA. 1992;267:1349-1353)
Author Affiliations
From the Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases (Drs Dykewicz, Fisher-Hoch, Ostroff, Gary, Schonberger, and McCormick and Ms Perez-Oronoz) and Division of Field Epidemiology, Epidemiology Program Office (Dr Howarth), Centers for Disease Control, Atlanta, Ga; and the New Jersey State Department of Health, Trenton (Dr Dato).
Footnotes
Reprint requests to Division of Viral and Rickettsial Diseases, Centers for Disease Control, 1600 Clifton Rd NE, Mailstop A32, Atlanta, GA 30333 (Dr Schonberger).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
HLA-A2-Restricted Protection against Lethal Lymphocytic Choriomeningitis
Botten et al.
J. Virol. 2007;81:2307-2317.
ABSTRACT
| FULL TEXT
Transmission of lymphocytic choriomeningitis virus by organ transplantation.
Fischer et al.
NEJM 2006;354:2235-2249.
ABSTRACT
| FULL TEXT
Natural Pathogens of Laboratory Mice, Rats, and Rabbits and Their Effects on Research
Baker
Clin. Microbiol. Rev. 1998;11:231-266.
ABSTRACT
| FULL TEXT
Congenital Lymphocytic Choriomeningitis Virus Syndrome: A Disease That Mimics Congenital Toxoplasmosis or Cytomegalovirus Infection
Wright et al.
Pediatrics 1997;100:e9-e9.
ABSTRACT
| FULL TEXT
|